发明名称 INHIBITORS OF SERINE PALMITOYLTRANSFERASE
摘要 This invention provides compounds of the formula: useful in the inhibition or modulation of serine palmitoyl transferase and their use in methods of treatment or amelioration of type 2 diabetes, type 1 diabetes, insulin resistance, the effects of obesity, metabolic syndrome (sometimes referred to as Syndrome X), impaired glucose tolerance, Cushing's disease, cardiovascular disease, prothrombotic conditions, myocardial infarction, hypertension, congestive heart failure, cardiomyopathy, atherosclerosis, dyslipidemia, sepsis, liver damage, retinal degenerative disorders, cachexia, emphysema, hepatitis C infections, HIV infections and inflammatory disorders and useful in methods for raising HDL plasma levels in a mammal. The compounds of this invention can also be used to prevent damage or loss of pancreatic islet beta cells (such as in the case of pancreatic beta cell apoptosis, including those related to insulin-dependent diabetes mellitus).
申请公布号 US2008287479(A1) 申请公布日期 2008.11.20
申请号 US20070945452 申请日期 2007.11.27
申请人 PFIZER INC 发明人 HUTCHINGS RICHARD;PARK WILLIAM;BOLTON GARY;VAN HUIS CHAD;KOHRT JEFF
分类号 A61K31/438;A61K31/439;A61K31/454;C07D401/14 主分类号 A61K31/438
代理机构 代理人
主权项
地址